Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis
about
Confirmation of the genetic association of CTLA4 and PTPN22 with ANCA-associated vasculitisMeta-analysis of haplotype-association studies: comparison of methods and empirical evaluation of the literatureCytotoxic T lymphocyte-associated antigen 4 gene polymorphisms and autoimmune thyroid diseases: an updated systematic review and cumulative meta-analysisCTLA4 and generalized vitiligo: two genetic association studies and a meta-analysis of published data.Toll-like receptor gene polymorphisms are associated with susceptibility to Graves' ophthalmopathy in Taiwan males.Polymorphisms of CLEC16A region and autoimmune thyroid diseases.Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.Thyroid autoimmunity and ophthalmopathy related to melanoma biological therapyThe genetics of the thyroid stimulating hormone receptor: history and relevanceHashimoto's Thyroiditis: From Genes to the Disease.Meta-analysis of genome-wide linkage studies across autoimmune diseases.Impaired proteasome function activates GATA3 in T cells and upregulates CTLA-4: relevance for Sézary syndromePolymorphisms of the TNFAIP3 region and Graves' disease.Foxp3⁺ regulatory T cells exert asymmetric control over murine helper responses by inducing Th2 cell apoptosis.A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantationThe genetic basis of graves' disease.Recipient CTLA-4*CT60-AA genotype is a prognostic factor for acute graft-versus-host disease in hematopoietic stem cell transplantation for thalassemia.Association of Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) and Thyroglobulin (TG) Genetic Variants with Autoimmune Hypothyroidism.Association of Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4) Gene Polymorphisms with Autoimmune Thyroid Disease in Children and Adults: Case-Control Study.Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.CTLA-4 gene polymorphisms and their influence on predisposition to autoimmune thyroid diseases (Graves' disease and Hashimoto's thyroiditis).Cytotoxic T-lymphocyte associated antigen 4 polymorphisms and asthma risk: a meta-analysis.Pooled genome wide association detects association upstream of FCRL3 with Graves' disease.Genetics of autoimmune thyroid disease in the Lebanese population.Recipient cytotoxic T lymphocyte antigen 4 +49 single-nucleotide polymorphism is not associated with acute rejection after liver transplantation in Chinese populationAssociation between genetic mutations and the development of autoimmune thyroiditis in patients with chronic hepatitis C treated with interferon alpha.A multilocus model of the genetic architecture of autoimmune thyroid disorder, with clinical implicationsAssociation between age at diagnosis of Graves' disease and variants in genes involved in immune response'Linkage analysis of thyroid antibody production: evidence for shared susceptibility to clinical autoimmune thyroid diseaseJoint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms.Recent insights into the pathogenesis and management of thyroid-associated ophthalmopathyGenetic developments in autoimmune thyroid disease: an evolutionary process.Ctla-4 expression and polymorphisms in lung tissue of patients with diagnosed non-small-cell lung cancer.Contemporary role of medical genetics in internal medicine.CTLA4 autoimmunity-associated genotype contributes to severe pulmonary tuberculosis in an African population.HIV/AIDS: immune reconstitution inflammatory syndrome: a reappraisal.CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.General and Specific Genetic Polymorphism of Cytokines-Related Gene in AITD.Diseases associated with thyroid autoimmunity: explanations for the expanding spectrum.How far are we from understanding the genetic basis of Hashimoto's thyroiditis?
P2860
Q21261514-884D1CC6-71ED-4D91-BEB5-01770183C2FFQ24288971-1269ABD0-A1C7-480F-8685-B3A67534999FQ26822772-B5BFC42A-A25B-4194-BAF0-0DE8F51933BBQ33403599-84B68DA7-5F90-4608-8DB0-FCA9945E3E6FQ33738336-AD5449AC-7E0F-4C8E-9BA3-4F632E9DA44FQ33785016-2DB345D2-6915-4501-9DB8-A54262C9F604Q33801427-C0F1E1E5-4778-49C4-A9E3-36E6610C50DBQ33841397-DDED08F4-B318-4D18-B1BA-0BA97DC67FFCQ34110141-BC7227CE-B0E1-4354-9263-53A86137026EQ34278457-2B195D0D-8C45-4D68-9F0E-44F19CA60D8AQ34325606-89C91984-FE7E-4594-986B-64469D22C9FDQ34824040-6244DA47-16EC-48DD-9931-7849C675125AQ35163330-5DE7B5A5-5BFC-455C-B0DA-290A5A7AC713Q35172468-2C38F510-012F-4351-95A3-60D99FC42713Q35594106-D9C13182-CC99-41F4-943E-EFE00523854FQ35730994-4C57A748-9199-49EB-AB31-4225E56D02E2Q35859478-124E6CDF-16FA-4375-B697-5B641A749E95Q35952507-7890ACE2-07E0-44C3-B2E2-D445B84C76B6Q35998164-31AABC5A-E774-46A7-8F50-5A207F8F55A6Q36070800-FF506DEC-B1AA-4A95-9F8A-F7F5A7B8459FQ36105659-5DD93440-83AB-4673-AC0A-A0641CC06EF7Q36120001-F60D94FA-5824-4EB8-B4C1-3FA386C14863Q36198104-26D9CB3E-BD25-48B9-BE44-E0CC85E3EDE8Q36288230-C0E8CC87-7529-4291-8071-0A649C4AA822Q36572966-6AEDC696-7693-4E6C-964F-0DB88997457FQ36630837-DA4E89BB-D83E-4E3D-8DE6-72C8C73D4FE9Q36719035-AE5221A4-F0CC-46DA-8550-2126B2C61498Q36721277-A939B2C9-C7C2-4473-8B57-1D61F38EF3CEQ36938349-8E30A3DF-C7F2-4B28-AFD9-D474825024A4Q36973929-3DCA3764-D31C-455B-8B7F-E848F77A9DC7Q37017200-37F41F08-E3A8-4F20-A059-B5720603782BQ37032887-D1B00A79-9272-46F5-B1EB-BE1DD128F0F1Q37044252-8AB00494-020A-43A7-AD3A-C691AD7CEA3EQ37180088-4B765F99-6497-4CC5-9A4E-6D32C7F63C0BQ37254718-5F9E9D8E-20E8-48B1-BD8E-57697E9AE7ABQ37331818-92620097-7016-4DB4-90A1-CA562BC463AFQ37578409-1EC09788-ED95-426F-8315-716D16825291Q37590849-0BFB55BF-B98B-4FE2-B7D4-6CECBB8E82DEQ37780783-523B64F0-1276-4B16-B154-FCB50AD21B24Q38101670-C58F541B-83EB-4DF9-AE67-2CF1CA386D9C
P2860
Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Cytotoxic T-lymphocyte associa ...... yroid disease: a meta-analysis
@ast
Cytotoxic T-lymphocyte associa ...... yroid disease: a meta-analysis
@en
Cytotoxic T-lymphocyte associa ...... yroid disease: a meta-analysis
@nl
type
label
Cytotoxic T-lymphocyte associa ...... yroid disease: a meta-analysis
@ast
Cytotoxic T-lymphocyte associa ...... yroid disease: a meta-analysis
@en
Cytotoxic T-lymphocyte associa ...... yroid disease: a meta-analysis
@nl
prefLabel
Cytotoxic T-lymphocyte associa ...... yroid disease: a meta-analysis
@ast
Cytotoxic T-lymphocyte associa ...... yroid disease: a meta-analysis
@en
Cytotoxic T-lymphocyte associa ...... yroid disease: a meta-analysis
@nl
P2093
P50
P921
P3181
P356
P1476
Cytotoxic T-lymphocyte associa ...... yroid disease: a meta-analysis
@en
P2093
Dimitry A Chistiakov
Edyta Pawlak
Emma I Chistiakova
Fotini K Kavvoura
Gholam-Hossein R Omrani
Hitomi Hiratani
Ikuyo Miyake
Irena Frydecka
Joanne M Heward
Marcin Chojm
P304
P3181
P356
10.1210/JC.2007-0147
P407
P577
2007-08-01T00:00:00Z